The global Point-of-Care Diagnostics market is projected to reach USD 38.13 Billion by 2022 from USD 23.71 Billion in 2017, at a CAGR of 10.0% during the forecast period. The report covers the Point-of-Care Diagnostics market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the Rapid Diagnostics Market in 2017, due to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives in this region.

Drivers:
1 High Prevalence of Infectious Diseases in Developing Countries
2 Increasing Incidence of Target Diseases
3 Rising Usage of Home-Based POC Devices
4 Growing Government Support
5 Technological Advancements and New Product Launches
6 Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
7 Shortage of Skilled Laboratory Technicians
8 Rising Number of Clia-Waived POC Tests

Restraints:
1 Product Recalls: Hampering User Confidence
2 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
3 Stringent and Time-Consuming Regulatory Policies are Significantly Increasing Gestation Period for Product Launches

PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=106829185

Opportunities:
1 Growth Opportunities in Emerging Markets
2 Healthcare Decentralization —Converting Lab Tests to POC Tests
3 Increasing Number of Conferences and Events
4 POC Tests With Multiplexing Capabilities

Challenges:
1 Lack of Alignment With Definitive Central Lab Methods
1.1 Disadvantages of POC Testing Over Central Lab Methods
2 Inadequate Knowledge About the Use of POC Devices in Professional Settings
3 Reluctance Towards Changing Existing Diagnostic Practices
4 High Cost of Devices

Market Key Players:

The major players of the Point-of-Care Diagnostics market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (US).

Know More: https://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html